HEPATITIS B IMMUNE GLOBULIN (HUMAN) (Nabi-HB) Nursing Considerations

What is the generic name?

HEPATITIS B IMMUNE GLOBULIN (HUMAN)

What is the Trade Name for HEPATITIS B IMMUNE GLOBULIN (HUMAN)?

Nabi-HB

What are the Indications for HEPATITIS B IMMUNE GLOBULIN (HUMAN)?

• INDICATIONS AND USAGE Nabi-HB, Hepatitis B Immune Globulin (Human), is indicated for treatment of acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infec- tion in the following settings: Acute Exposure to Blood Containing HBsAg: Following either parenteral exposure (needlestick, bite, sharps), direct mucous membrane contact (accidental splash), or oral ingestion (pipetting accident), involving HBsAg-positive materials such as blood, plasma, or serum. Perinatal Exposure of Infants Born to HBsAg-positive Mothers: Infants born to mothers positive for HBsAg with or without HBeAg 12 . Sexual Exposure to HBsAg-positive Persons: Sexual partners of HBsAg-positive persons. Household Exposure to Persons with Acute HBV Infection: Infants less than 12 months old whose mother or primary caregiver is positive for HBsAg. Other household contacts with an identifiable blood exposure to the index patient. Nabi-HB is indicated for intramuscular use only.

References: https://open.fda.gov/